ETF Holdings Breakdown of TBPH

News associated with TBPH

Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC grew its position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 142.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,670 shares of the biopharmaceutical company’s stock after purchasing an additional 7,452 shares during the period. Tower Research Capital […] - 2025-05-09 08:22:54

Barclays PLC Raises Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)

Barclays PLC increased its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 14.0% in the 4th quarter, HoldingsChannel reports. The firm owned 74,790 shares of the biopharmaceutical company’s stock after purchasing an additional 9,210 shares during the period. Barclays PLC’s holdings in Theravance Biopharma were worth $704,000 as of its most […] - 2025-05-08 07:36:46

XTX Topco Ltd Reduces Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH)

XTX Topco Ltd lessened its holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 20.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 16,356 shares of the biopharmaceutical company’s stock after selling 4,083 shares during the period. XTX Topco Ltd’s holdings in Theravance […] - 2025-04-29 08:24:51

10,937 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Teacher Retirement System of Texas

Teacher Retirement System of Texas acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,937 shares of the biopharmaceutical company’s stock, valued at approximately $103,000. Other institutional investors have […] - 2025-04-03 07:16:48

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of “Hold” by Analysts

Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been assigned a consensus rating of “Hold” from the five brokerages that are covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average twelve-month price […] - 2025-03-27 06:55:16

Bank of New York Mellon Corp Sells 5,282 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH)

Bank of New York Mellon Corp trimmed its stake in Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 115,779 shares of the biopharmaceutical company’s stock after selling 5,282 shares during the quarter. Bank of New York Mellon Corp’s holdings in Theravance Biopharma were worth $1,089,000 […] - 2025-03-25 07:14:50

Theravance Biopharma (NASDAQ:TBPH) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […] - 2025-02-26 08:49:00

TBPH institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-03-04	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	159 -46.5%	USD 1,447 -47.3%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	23,115	USD 228,839 -0.9%
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	23,115	USD 228,839 -0.9%
Total =		46,389	USD 459,125

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer